摘要 |
<p>The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II, and methods for the treatment of respiratory diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of asthma, bronchiectasis, chronic obstructive lung disease including COPD, bronchitis and emphysema, chronic rhinosinusitis, hypersensitivity pneumonitis, lung cancer and neoplasms of respiratory and intrathoracic organs, lung fibrosis, chronic pleural disease, pneumoconiosis, pulmonary eosinophilia, pulmonary heart disease and diseases of pulmonary circulation including pulmonary embolism, pulmonary hypertension and rhinitis, sarcoidosis, sleep apnoea syndrome.</p> |